st. jude medical

While the fate of the 2010 health care reform law may rest in the hands of the Supreme Court, the nation's focus on health care has returned for the moment. For investors, the following health care picks all pay a dividend and have seen double-digit percentage growth in their share price since the...

Here's a quick look at some of the top performing health care stocks, year to date. These stocks all have a market cap of more than $1 billion and all pay a dividend. Baxter International (NYSE: BAX) is more than 11% higher than a month ago, and more than 17% higher than a year ago. The company...

The earnings crunch rolls on this week. Among those scheduled to step into the spotlight are Apple (NASDAQ: AAPL), Caterpillar (NYSE: CAT), Chevron (NYSE: CVX), McDonald's (NYSE: MCD) and Starbucks (NASDAQ: SBUX). Analysts expect them post year-over-year earnings growth. AT&T (NYSE: T), Boeing...

The earnings season ramps up this week. Tech giants Apple (NASDAQ: AAPL), Microsoft (NYSE: MSFT), Intel (NASDAQ: INTC) and IBM (NYSE: IBM) are scheduled to share their third-quarter results, as are big banks including Bank of America (NYSE: BAC), Citigroup (NYSE: C), Goldman Sachs (NYSE: GS),...

Citi is out with its report today on St. Jude Medical (NYSE: STJ), maintaining Sell. In a note to clients, Citi writes, "2Q11 results made it clear to us that bullish commentary on share gains and new products is not going to drive results anytime soon with 55% of sales tied to a struggling CRM...

Earnings season ramps up this week with quarterly reports due from the likes of tech companies such as IBM (NYSE: IBM) and Microsoft (NASDAQ: MSFT), big banks such as Wells Fargo (NYSE: WFC) and Bank of America (NYSE: BAC), and consumer goods giants such as PepsiCo (NYSE: PEP) and Johnson &...

PowerShares S&P SmallCap Health Care (NYSE: PSCH) is up nearly 22% year to date. The investment seeks to replicate the S&P SmallCap 600 Capped Health Care index, which is comprised of common stocks of U.S. health care companies. Top holdings include Regeneron Pharmaceuticals (NASDAQ: REGN...

J.P. Morgan is out with its report today on St. Jude Medical (NYSE: STJ), maintaining Overweight. In a note to clients, J.P. Morgan writes, "We view St. Jude as the best growth story in large-cap MedTech, with the potential to post a sustainable 7% top-line CAGR over the next 3-5 years driven by 1...

Bank of America Merrill Lynch is out with its report today on St. Jude Medical (NYSE: STJ), maintaining Buy. In a note to clients, Bank of America Merrill Lynch writes, "STJ trades at no meaningful premium to the group despite what we view as a solidly superior growth outlook on the top and bottom...

Deutsche Bank has raised the price target on St. Jude Medical (NYSE: STJ) from $57 to $60 and maintains its Buy rating.

J.P. Morgan is reiterating its Overweight rating on shares of St. Jude Medical Inc. (NYSE: STJ). “St. Jude reported strong 1Q results Wednesday morning,” J.P. Morgan writes. “Revenues of $1.376B increased 9.0% reported and 4.6% organic, in-line with consensus. Sales were driven by a solid...

Jefferies is out with its report today on St. Jude Medical (NYSE: STJ), maintaining Buy. In a note to clients, Jefferies writes, "New product flow and the momentum from the ICD generator replacement cycle tailwind should fuel market share growth for STJ in the near-term. Portfolio diversification...

Deutsche Bank has upgraded St. Jude Medical (NYSE: STJ) from Hold to Buy and has raised the price target from $45 to $52.

Piper Jaffray has raised the price target on St. Jude Medical, Inc. (NYSE: STJ) from $46 to $52 and maintains its Overweight rating.

Wells Fargo is downgrading St. Jude Medical, Inc. (NYSE: STJ) to Market Perform from Outperform “because we expect the US ICD market to suffer from a near-term reduction in implants of about 10% due to the announcement by the Heart Rhythm Society (HRS) on January 20th that it is advising the...